| Metric | შპს ნიუ ფარმა NEW PHARMA | შპს მედ ფარმასი გრუპი |
|---|---|---|
| Growth | ||
| Revenue | ₾883₾4.1m | ₾1.5m₾2.3m |
| Revenue growth | -100.0% | -35.4% |
| Profitability | ||
| EBITDA | -₾262k-₾476k | -₾565k₾70k |
| EBITDA margin | -29687.2%-11.6% | -38.3%3.1% |
| Net profit | -₾258k-₾726k | -₾582k₾13k |
| Net margin | -29249.2%-17.7% | -39.5%0.6% |
| Balance sheet | ||
| Total assets | ₾83k₾1.4m | ₾1.1m₾1.5m |
| Total equity | -₾780k-₾522k | ₾720k₾1.3m |
| ROE | — | -80.9%1.0% |